SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 254 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266,326 | +8.0% | 9,660 | +17.7% | 0.02% | +15.4% |
| Q2 2023 | $246,672 | -20.7% | 8,206 | -4.4% | 0.01% | -31.6% |
| Q1 2023 | $311,143 | +27.0% | 8,588 | +16.5% | 0.02% | +26.7% |
| Q4 2018 | $245,000 | -50.8% | 7,373 | -25.5% | 0.02% | -21.1% |
| Q3 2018 | $498,000 | -26.4% | 9,896 | -12.5% | 0.02% | -29.6% |
| Q2 2018 | $677,000 | +45.6% | 11,310 | +11.5% | 0.03% | +42.1% |
| Q1 2018 | $465,000 | +57.1% | 10,148 | +36.6% | 0.02% | +72.7% |
| Q4 2017 | $296,000 | +17.0% | 7,429 | +17.5% | 0.01% | 0.0% |
| Q3 2017 | $253,000 | -36.4% | 6,322 | -31.6% | 0.01% | -38.9% |
| Q2 2017 | $398,000 | +45.8% | 9,243 | +6.0% | 0.02% | +50.0% |
| Q1 2017 | $273,000 | +11.4% | 8,717 | -10.2% | 0.01% | +9.1% |
| Q4 2016 | $245,000 | – | 9,703 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 42,189 | $1,220,950 | 0.03% |
| MASSMUTUAL TRUST CO FSB/ADV | 320 | $9,261 | 0.00% |
| Versant Capital Management, Inc | 16 | $463 | 0.00% |